Profile
Luigi Colombo is the founder of Biosearch Italia SpA, which was founded in 1996.
He is currently the Chief Executive Officer at SilverAid SRL, the Director at Nocturnal Labs SpA, and the Chief Operating Officer at EPOK Therapeutics, Inc. (starting in 2023).
Mr. Colombo previously worked as the Executive Director at Ulisse BioMed SpA. He obtained his undergraduate degree from the University of Milan.
Luigi Colombo active positions
| Companies | Position | Start |
|---|---|---|
SilverAid SRL
SilverAid SRL Medical SpecialtiesHealth Technology Designs, develops, produces and distributes dental equipment | Chief Executive Officer | - |
EPOK Therapeutics, Inc.
EPOK Therapeutics, Inc. BiotechnologyHealth Technology Develops biologics to treat metabolic diseases | Chief Operating Officer | 2023-01-31 |
Nocturnal Labs SpA | Director/Board Member | - |
Former positions of Luigi Colombo
| Companies | Position | End |
|---|---|---|
| HELYX INDUSTRIES S.P.A. | Director/Board Member | - |
Biosearch Italia SpA
Biosearch Italia SpA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Founder | - |
Education of Luigi Colombo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Biosearch Italia SpA
Biosearch Italia SpA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ulisse BioMed SpA
Ulisse BioMed SpA Medical SpecialtiesHealth Technology Develops and manufactures diagnostic platforms and products | Health Technology |
SilverAid SRL
SilverAid SRL Medical SpecialtiesHealth Technology Designs, develops, produces and distributes dental equipment | Health Technology |
EPOK Therapeutics, Inc.
EPOK Therapeutics, Inc. BiotechnologyHealth Technology Develops biologics to treat metabolic diseases | Health Technology |
Nocturnal Labs SpA |
- Stock Market
- Insiders
- Luigi Colombo
















